APA (7th ed.) Citation

Kawata, T., Tada, K., Kobayashi, M., Sakamoto, T., Takiuchi, Y., Iwai, F., . . . Takaori‐Kondo, A. (2018). Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T‐cell leukemia. Cancer science, 109(1), 103-111. https://doi.org/10.1111/cas.13431

Chicago Style (17th ed.) Citation

Kawata, Takahito, et al. "Dual Inhibition of the MTORC1 and MTORC2 Signaling Pathways Is a Promising Therapeutic Target for Adult T‐cell Leukemia." Cancer Science 109, no. 1 (2018): 103-111. https://doi.org/10.1111/cas.13431.

MLA (9th ed.) Citation

Kawata, Takahito, et al. "Dual Inhibition of the MTORC1 and MTORC2 Signaling Pathways Is a Promising Therapeutic Target for Adult T‐cell Leukemia." Cancer Science, vol. 109, no. 1, 2018, pp. 103-111, https://doi.org/10.1111/cas.13431.